1. Home
  2. IMVT vs AMR Comparison

IMVT vs AMR Comparison

Compare IMVT & AMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • AMR
  • Stock Information
  • Founded
  • IMVT 2018
  • AMR 2016
  • Country
  • IMVT United States
  • AMR United States
  • Employees
  • IMVT N/A
  • AMR N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • AMR Coal Mining
  • Sector
  • IMVT Health Care
  • AMR Energy
  • Exchange
  • IMVT Nasdaq
  • AMR Nasdaq
  • Market Cap
  • IMVT 2.7B
  • AMR 2.1B
  • IPO Year
  • IMVT N/A
  • AMR N/A
  • Fundamental
  • Price
  • IMVT $16.00
  • AMR $165.09
  • Analyst Decision
  • IMVT Buy
  • AMR Buy
  • Analyst Count
  • IMVT 10
  • AMR 4
  • Target Price
  • IMVT $33.38
  • AMR $168.00
  • AVG Volume (30 Days)
  • IMVT 1.7M
  • AMR 311.2K
  • Earning Date
  • IMVT 11-06-2025
  • AMR 11-06-2025
  • Dividend Yield
  • IMVT N/A
  • AMR N/A
  • EPS Growth
  • IMVT N/A
  • AMR N/A
  • EPS
  • IMVT N/A
  • AMR N/A
  • Revenue
  • IMVT N/A
  • AMR $2,371,475,000.00
  • Revenue This Year
  • IMVT N/A
  • AMR N/A
  • Revenue Next Year
  • IMVT N/A
  • AMR $25.30
  • P/E Ratio
  • IMVT N/A
  • AMR N/A
  • Revenue Growth
  • IMVT N/A
  • AMR N/A
  • 52 Week Low
  • IMVT $12.72
  • AMR $97.41
  • 52 Week High
  • IMVT $32.10
  • AMR $255.04
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 50.79
  • AMR 56.50
  • Support Level
  • IMVT $15.81
  • AMR $163.36
  • Resistance Level
  • IMVT $17.15
  • AMR $176.81
  • Average True Range (ATR)
  • IMVT 0.73
  • AMR 7.22
  • MACD
  • IMVT 0.10
  • AMR -0.39
  • Stochastic Oscillator
  • IMVT 57.98
  • AMR 32.43

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

Share on Social Networks: